COMPANION MEETINGS

Endocrine Pathology Society




  Saturday, March 20, 2010 — 7:00 PM, Salon 1  
  • New Insight in the Encapsulated Thyroid Follicular Cell Tumors
  Moderators: Kennichi Kakudo, Wakayama Medical University, Wakayama City, Japan and
Virginia LiVolsi, University of Pennsylvania, Philadelphia, PA
  Disclosure: In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Virginia LiVolsi is a consultant for Veracyte. The other speakers listed below have indicated they have nothing to disclose.




Click the button above to add this event to your Itinerary Planner...



7:00  Capsule of Follicular Cell Tumors, its Significance and Morphology - Ryohei Katoh, Tadao Nakazawa and Tetsuo Kondo, University of Yamanashi, Yamanashi, Japan
7:30  Encapsulated Malignant Follicular Cell-derived Tumors - Ronald Ghossein, Memorial Sloan Kettering Cancer Center, New York, NY
8:00  Familial Follicular Cell Tumors: Classification and Morphological Characteristics - Vania Nose, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
8:30  Genetic Aspects of Encapsulated Follicular Cell Tumors - Thomas Giordano, University of Michigan, Ann Harbor, MI
The topics of the program were chosen by an informal poll of members, a review of the programs from recent meetings, and consultations with current and past office bearers of the society, based upon the recent advances and difficulties in classification in selected thyroid follicular cell tumors. This symposium highlights problematic diagnostic areas in the diagnosis of encapsulated follicular cell tumors, benign and malignant, sporadic and familial. There will be an initial discussion on the significance of capsule of follicular cell tumors, on malignant follicular cell-derived tumors from the morphology to the new molecular aspects, on familial follicular cell tumors including classification and morphological characteristics to genetic aspects of encapsulated ollicular cell tumors. The objective of the program is to update general surgical pathologists to recognize important diagnostic, clinicopathologic, and molecular features in selected and difficult thyroid follicular cell tumors.